Literature DB >> 28803886

A method for extracting and characterizing RNA from urine: For downstream PCR and RNAseq analysis.

Kun Zhou1, Monique A Spillman2, Kian Behbakht3, Julia M Komatsu1, Juan E Abrahante4, Douglas Hicks3, Brent Schotl1, Evan Odean1, Kenneth L Jones3, Michael W Graner3, Lynne T Bemis5.   

Abstract

Readily accessible samples such as urine or blood are seemingly ideal for differentiating and stratifying patients; however, it has proven a daunting task to identify reliable biomarkers in such samples. Noncoding RNA holds great promise as a source of biomarkers distinguishing physiologic wellbeing or illness. Current methods to isolate and characterize RNA molecules in urine are limited. In this proof of concept study, we present a method to extract and identify small noncoding RNAs in urine. Initially, quantitative reverse transcription PCR was applied to confirm the presence of microRNAs in total RNA extracted from urine. Once the presence of micro RNA in urine was confirmed, we developed a method to scale up RNA extraction to provide adequate amounts of RNA for next generation sequence analysis. The method described in this study is applicable to detecting a broad range of small noncoding RNAs in urine; thus, they have wide applicability for health and disease analyses.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Extracellular RNA in urine; Noncoding RNA; Ovarian cancer; Small RNA next generation sequencing; tRNA fragments

Mesh:

Substances:

Year:  2017        PMID: 28803886      PMCID: PMC6278937          DOI: 10.1016/j.ab.2017.08.003

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  60 in total

Review 1.  Slicing tRNAs to boost functional ncRNA diversity.

Authors:  Jennifer Gebetsberger; Norbert Polacek
Journal:  RNA Biol       Date:  2013-11-21       Impact factor: 4.652

2.  Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.

Authors:  Marina Bagnoli; Silvana Canevari; Daniela Califano; Simona Losito; Massimo Di Maio; Francesco Raspagliesi; Maria Luisa Carcangiu; Giuseppe Toffoli; Erika Cecchin; Roberto Sorio; Vincenzo Canzonieri; Daniela Russo; Giosué Scognamiglio; Gennaro Chiappetta; Gustavo Baldassarre; Domenica Lorusso; Giovanni Scambia; Gian Franco Zannoni; Antonella Savarese; Mariantonia Carosi; Paolo Scollo; Enrico Breda; Viviana Murgia; Francesco Perrone; Sandro Pignata; Loris De Cecco; Delia Mezzanzanica
Journal:  Lancet Oncol       Date:  2016-07-09       Impact factor: 41.316

Review 3.  Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.

Authors:  Ke Zen; Chen-Yu Zhang
Journal:  Med Res Rev       Date:  2010-11-09       Impact factor: 12.944

4.  Evolving Approaches in Research and Care for Ovarian Cancers: A Report From the National Academies of Sciences, Engineering, and Medicine.

Authors:  Douglas A Levine; Beth Y Karlan; Jerome F Strauss
Journal:  JAMA       Date:  2016-05-10       Impact factor: 56.272

5.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

Review 6.  The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids.

Authors:  Marta Fernandez-Mercado; Lorea Manterola; Erika Larrea; Ibai Goicoechea; María Arestin; María Armesto; David Otaegui; Charles H Lawrie
Journal:  J Cell Mol Med       Date:  2015-06-27       Impact factor: 5.310

7.  tRNAscan-SE On-line: integrating search and context for analysis of transfer RNA genes.

Authors:  Todd M Lowe; Patricia P Chan
Journal:  Nucleic Acids Res       Date:  2016-05-12       Impact factor: 16.971

Review 8.  Emerging concepts in liquid biopsies.

Authors:  Samantha Perakis; Michael R Speicher
Journal:  BMC Med       Date:  2017-04-06       Impact factor: 8.775

9.  Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.

Authors:  Stacia K Wyman; Rachael K Parkin; Patrick S Mitchell; Brian R Fritz; Kathy O'Briant; Andrew K Godwin; Nicole Urban; Charles W Drescher; Beatrice S Knudsen; Muneesh Tewari
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

Review 10.  Extracellular microRNAs in urologic malignancies: chances and challenges.

Authors:  Xiaoyi Huang; Meihua Liang; Rachel Dittmar; Liang Wang
Journal:  Int J Mol Sci       Date:  2013-07-16       Impact factor: 5.923

View more
  4 in total

1.  Biofluids manipulation methods for liquid biopsy in minimally-invasive assays.

Authors:  Valeria Garzarelli; Francesco Ferrara; Elisabetta Primiceri; Maria Serena Chiriacò
Journal:  MethodsX       Date:  2022-06-17

2.  Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection.

Authors:  Marc Hirschfeld; Gerta Rücker; Daniela Weiß; Kai Berner; Andrea Ritter; Markus Jäger; Thalia Erbes
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

3.  Diversity and signature of small RNA in different bodily fluids using next generation sequencing.

Authors:  Mohamed El-Mogy; Bernard Lam; Taha A Haj-Ahmad; Shannon McGowan; Darrick Yu; Lucas Nosal; Nezar Rghei; Pam Roberts; Yousef Haj-Ahmad
Journal:  BMC Genomics       Date:  2018-05-29       Impact factor: 3.969

4.  The Urinary Transcriptome as a Source of Biomarkers for Prostate Cancer.

Authors:  Carla Solé; Ibai Goicoechea; Alai Goñi; Maike Schramm; María Armesto; María Arestin; Lorea Manterola; Maitena Tellaetxe; Aitor Alberdi; Leonor Nogueira; Mathieu Roumiguie; Jose Ignacio López; Juan Pablo Sanz Jaka; Ander Urruticoechea; Itziar Vergara; Ana Loizaga-Iriarte; Miguel Unda; Arkaitz Carracedo; Bernard Malavaud; Charles H Lawrie
Journal:  Cancers (Basel)       Date:  2020-02-22       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.